These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24798621)

  • 21. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
    Angelico M; Nardi A; Romagnoli R; Marianelli T; Corradini SG; Tandoi F; Gavrila C; Salizzoni M; Pinna AD; Cillo U; Gridelli B; De Carlis LG; Colledan M; Gerunda GE; Costa AN; Strazzabosco M;
    Dig Liver Dis; 2014 Apr; 46(4):340-7. PubMed ID: 24411484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling.
    Diémé B; Halimi JM; Emond P; Büchler M; Nadal-Desbarat L; Blasco H; Le Guellec C
    Transplantation; 2014 Jul; 98(2):195-201. PubMed ID: 24598938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
    Lee DD; Croome KP; Shalev JA; Musto KR; Sharma M; Keaveny AP; Taner CB
    Ann Hepatol; 2016; 15(1):53-60. PubMed ID: 26626641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic profiles and predictors of early allograft dysfunction after human liver transplantation.
    Kurian SM; Fouraschen SM; Langfelder P; Horvath S; Shaked A; Salomon DR; Olthoff KM
    Am J Transplant; 2015 Jun; 15(6):1605-14. PubMed ID: 25828101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
    Spitzer AL; Lao OB; Dick AA; Bakthavatsalam R; Halldorson JB; Yeh MM; Upton MP; Reyes JD; Perkins JD
    Liver Transpl; 2010 Jul; 16(7):874-84. PubMed ID: 20583086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.
    Salvalaggio PR; Felga GE; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2449-51. PubMed ID: 23026617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers.
    Marroquin CE; Marino G; Kuo PC; Plotkin JS; Rustgi VK; Lu AD; Edwards E; Taranto S; Johnson LB
    Liver Transpl; 2001 Sep; 7(9):762-8. PubMed ID: 11552208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of liver graft sonographic grading and point shear wave elastography to reduce early allograft dysfunction after liver transplantation.
    Liu WY; Li XX; Fu XY; Wu XD; Wang X; Guo Y; Zang YJ; Wang JH
    Eur Radiol; 2020 Sep; 30(9):5191-5199. PubMed ID: 32328762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia.
    Totsuka E; Dodson F; Urakami A; Moras N; Ishii T; Lee MC; Gutierrez J; Gerardo M; Molmenti E; Fung JJ
    Liver Transpl Surg; 1999 Sep; 5(5):421-8. PubMed ID: 10477844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations.
    García-Cañaveras JC; Donato MT; Castell JV; Lahoz A
    J Proteome Res; 2011 Oct; 10(10):4825-34. PubMed ID: 21830829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival following liver transplantation from non-heart-beating donors.
    Abt PL; Desai NM; Crawford MD; Forman LM; Markmann JW; Olthoff KM; Markmann JF
    Ann Surg; 2004 Jan; 239(1):87-92. PubMed ID: 14685105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A score model for the continuous grading of early allograft dysfunction severity.
    Pareja E; Cortes M; Hervás D; Mir J; Valdivieso A; Castell JV; Lahoz A
    Liver Transpl; 2015 Jan; 21(1):38-46. PubMed ID: 25204890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfusate Enzymes and Platelets Indicate Early Allograft Dysfunction After Transplantation of Normothermically Preserved Livers.
    Weissenbacher A; Bogensperger C; Oberhuber R; Meszaros A; Gasteiger S; Ulmer H; Berchtold V; Krendl FJ; Fodor M; Messner F; Hautz T; Otarashvili G; Resch T; Margreiter C; Maglione M; Irsara C; Griesmacher A; Raynaud M; Breitkopf R; Troppmair J; Öfner D; Cardini B; Schneeberger S
    Transplantation; 2022 Apr; 106(4):792-805. PubMed ID: 34144552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death.
    Xie H; Zhang L; Guo D; Yang Z; Zhu H; Zhou K; Feng X; Wei Q; Xu X; Song P; Wen X; Li J; Liu J; Zheng S
    Transplantation; 2020 Jan; 104(1):79-89. PubMed ID: 31283675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of lactate clearance for the development of early allograft dysfunction and short-term prognosis in deceased donor liver transplantation.
    Kim DG; Lee JY; Jung YB; Song SH; Lee JG; Han DH; Joo DJ; Ju MK; Choi GH; Choi JS; Kim MS; Kim SI
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 29032588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the Predictive Ability for Graft Loss and Mortality of Two Criteria for Early Allograft Dysfunction After Liver Transplantation.
    Brea-Gómez E; Villar-Quintana R; Plata-Illescas C; Zambudio-Carroll N; Lopez-Garrido MA; Nogueras-Lopez F; Muffak-Granero K; Becerra-Massare A; Villegas-Herrera MT; Segura Jiménez I; Muñoz Pérez N; Villar-Del-Moral JM
    Transplant Proc; 2018 Mar; 50(2):605-609. PubMed ID: 29579865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation.
    Legido-Quigley C; McDermott L; Vilca-Melendez H; Murphy GM; Heaton N; Lindon JC; Nicholson JK; Holmes E
    Electrophoresis; 2011 Aug; 32(15):2063-70. PubMed ID: 21732555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily determination of individual serum bile acids allows early detection of hepatic allograft dysfunction.
    Azer SA; McCaughan GW; Stacey NH
    Hepatology; 1994 Dec; 20(6):1458-64. PubMed ID: 7982645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.